retatrutide clinical trial results 2024 2025 press release I personally know plenty of people who have been sourcing (or powder they believe is reta) on the black market for the past few months. Social media is awash with posts Retatrutide produces up to 30.3%

How can the Precision Peptide Genetic Test optimize my GLP-1 therapy

In line with reports indicating that PPAR may act on hypothalamic neurocircuitries 5,6 , we identified a series of new PPAR protein targets in the hypothalamus that are acutely upregulated by tesaglitazar and by GLP-1RA/tesaglitazar, but not by treatment with the GLP-1RA

Labeling update (2026): The FDA recently removed suicidal behavior and ideation language from the labeling of certain GLP-1 medicines used for chronic weight management, following a comprehensive safety review that found no evidence of increased risk

Advantages of the Non-DAC Configuration The deliberate omission of the Drug Affinity Complex (DAC) in the GHRH analog is a critical feature for high-resolution laboratory profiling